GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Roivant Sciences Ltd (STU:87S) » Definitions » Pretax Margin %

Roivant Sciences (STU:87S) Pretax Margin % : -2,600.56% (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Roivant Sciences Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Roivant Sciences's Pre-Tax Income for the three months ended in Dec. 2024 was €-224.0 Mil. Roivant Sciences's Revenue for the three months ended in Dec. 2024 was €8.6 Mil. Therefore, Roivant Sciences's pretax margin for the quarter that ended in Dec. 2024 was -2,600.56%.

The historical rank and industry rank for Roivant Sciences's Pretax Margin % or its related term are showing as below:

STU:87S' s Pretax Margin % Range Over the Past 10 Years
Min: -3776.2   Med: -1834.8   Max: 3408.33
Current: -473.65


STU:87S's Pretax Margin % is ranked worse than
65.74% of 1007 companies
in the Biotechnology industry
Industry Median: -145.89 vs STU:87S: -473.65

Roivant Sciences Pretax Margin % Historical Data

The historical data trend for Roivant Sciences's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roivant Sciences Pretax Margin % Chart

Roivant Sciences Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Pretax Margin %
-3,776.16 -1,670.84 -1,998.73 3,408.35

Roivant Sciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33,117.04 -410.63 127.23 -5,014.11 -2,600.56

Competitive Comparison of Roivant Sciences's Pretax Margin %

For the Biotechnology subindustry, Roivant Sciences's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Roivant Sciences's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Roivant Sciences's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Roivant Sciences's Pretax Margin % falls into.



Roivant Sciences Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Roivant Sciences's Pretax Margin for the fiscal year that ended in Mar. 2024 is calculated as

Pretax Margin=Pre-Tax Income (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=3913.156/114.811
=3,408.35 %

Roivant Sciences's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-223.96/8.612
=-2,600.56 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Roivant Sciences  (STU:87S) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Roivant Sciences Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Roivant Sciences's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Roivant Sciences Business Description

Traded in Other Exchanges
Address
50 Broadway, 7th Floor, London, GBR, SW1H 0BD
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Roivant Sciences Headlines

No Headlines